Total item
Cart Subtotal
$0.00 Customer Appreciation Sale.
15% off with promo code "APPRECIATION2023" on check out or purchase order
- Hirosumi Tamura, .et al. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues, Oncol Rep, 2018, Aug; 40(2): 635-646 PMID: 29917168
Biological Activity
Brivanib (BMS-540215) is a VEGFR -2 inhibitor with an IC50 of 25 nM and Ki of 26 nM.
Targets
| Target | Value |
|---|---|
| VEGFR2 | IC50: 25nM |
| Flk1 | IC50: 89nM |
| FGFR1 | IC50: 148nM |
| VEGFR1 | IC50: 380nM |
| EGFR | IC50: >1.9μM |
| LCK | IC50: >2.5μM |
| PDGFRβ | IC50: >6μM |
| PKCα | IC50: >25μM |
| JAK3 | IC50: >50μM |
| In vitro | DMSO | 71 mg/mL (191.69 mM) | |
| Water | Insoluble | ||
| Ethanol | 3 mg/mL (8.09 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 27 mL | 134.99 mL | 269.98 mL |
| 0.5 mM | 5.4 mL | 27 mL | 54 mL |
| 1 mM | 2.7 mL | 13.5 mL | 27 mL |
| 5 mM | 0.54 mL | 2.7 mL | 5.4 mL |
*The above data is based on the productmolecular weight 370.4. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A10254 |
|---|---|
| Actions | Inhibitor |
| CAS No. | 649735-46-6 |
| Formula | C19H19FN4O3 |
| M. Wt | 370.4 |
| Purity | >98% |
| Synonyms | BMS540215 |
| SMILES | CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[[email protected]@H](C)O)C |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
Vandetanib (ZD6474)
Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9…
Apatinib (YN968D1)
Apatinib (YN968D1) is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also …
Motesanib (AMG706)
Motesanib (AMG706) is a multikinase inhibitor that selectively targets VEGF receptors, platelet-derived growth factor receptors (PDGFRs), an…
TSU-68 (Orantinib, SU6668)
Orantinib (TSU-68, SU6668) has greatest potency against PDGFR autophosphorylation with Ki of 8 nM in a cell-free assay, but also strongly in…
BMS-690514
BMS-690514 is a potent and selective inhibitor of epidermal growth factor receptor (EGFR), HER2, and HER4, as well as the VEGF receptor kina…
E-3810
E-3810 is a potent and selective dual inhibitor of VEGF and FGF receptors with IC50 values of 7 nM, 25 nM, 10 nM, 17.5 nM and 82.5 nM for VE…
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf. Regorafenib (BAY 73-4506) is an ora…
Raf265 derivative
Raf265 derivative is a derivative of Raf265 that is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 μM.
Keywords:buy Brivanib (BMS-540215) | Brivanib (BMS-540215) Supplier | purchase | cost | manufacturer | order | distributor | buy 649735-46-6| 649735-46-6 Supplier | purchase 649735-46-6 | 649735-46-6 cost | 649735-46-6 manufacturer | order 649735-46-6 | 649735-46-6 distributor
Adooq Quality Guarantee
We promise all products perform as described.